Cited by 1,095Advanced Glycation End Products researchPotato Plant ResearchChronic Kidney Disease and Diabetes

The DOI matches its Crossref record; 169 of the 172 references it cites were found in a registry or an index, and 1 are not checked yet.

Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus

Open access
Nowotny, Kerstin, Jung, Tobias, Höhn, Annika, Weber, Daniela, Grune, Tilman·2015·Biomolecules

Abstract

Type 2 diabetes mellitus (T2DM) is a very complex and multifactorial metabolic disease characterized by insulin resistance and β cell failure leading to elevated blood glucose levels. Hyperglycemia is suggested to be the main cause of diabetic complications, which not only decrease life quality and expectancy, but are also becoming a problem regarding the financial burden for health care systems. Therefore, and to counteract the continually increasing prevalence of diabetes, understanding the pathogenesis, the main risk factors, and the underlying molecular mechanisms may establish a basis for prevention and therapy. In this regard, research was performed revealing further evidence that oxidative stress has an important role in hyperglycemia-induced tissue injury as well as in early events relevant for the development of T2DM. The formation of advanced glycation end products (AGEs), a group of modified proteins and/or lipids with damaging potential, is one contributing factor. On the one hand it has been reported that AGEs increase reactive oxygen species formation and impair antioxidant systems, on the other hand the formation of some AGEs is induced per se under oxidative conditions. Thus, AGEs contribute at least partly to chronic stress conditions in diabetes. As AGEs are not only formed endogenously, but also derive from exogenous sources, i.e., food, they have been assumed as risk factors for T2DM. However, the role of AGEs in the pathogenesis of T2DM and diabetic complications—if they are causal or simply an effect—is only partly understood. This review will highlight the involvement of AGEs in the development and progression of T2DM and their role in diabetic complications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biom5010194

Cites

169 of 170 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 172 references

2 of the 172 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Items 301–400 of 1,001

Metadata

Authors
Nowotny, K., Jung, T., Höhn, A., Weber, D., & Grune, T.
Affiliations
German Institute of Human Nutrition (DE)
Corresponding author
Grune, Tilman
Venue
Biomolecules
Publisher
MDPI AG
Published
2015-03-16
Volume
5
Issue
1
Pages
194-222
ISSN
2218-273X (ISSN-L)
OpenAlex
W1986014108
Cited by
1,095
References
172
Citations by year
2026: 59 · 2025: 93 · 2024: 106 · 2023: 138 · 2022: 132 · 2021: 118 · 2020: 106 · 2019: 99 · 2018: 99 · 2017: 68 · 2016: 61 · 2015: 14
FWCI
8.00
Type
journal article
Language
en
Open access
Locations
  • Biomolecules (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Potato Plant Research
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
advanced glycation end products, oxidative stress, type 2 diabetes, hyperglycemia, reactive oxygen species, antioxidant defense, diabetes complications, insulin resistance, beta-cell failure
MeSH terms
Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Cell Death, Glycation End Products, Advanced, Oxidative Stress, Insulin-Secreting Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review